FAVEA – Stable Czech Company with Unique Technologies

Only a few Czech medium-sized businesses, both in Czechia and worldwide, can be proud of such a wide variety of distinctive qualities. A company that does not make uniform products, and still meets all the quality standards, is a stable, long-term market player, and does not have many competitors. This is FAVEA – the Czech pharmaceutical company, specialising in complete services related to the development, production and registration of health nutrition supplements, skincare products, and food substances.

Since its foundation in 1994 in Silesian Kopřivnice, FAVEA has followed up on the best traditions of the Czech pharmaceutical industry and has taken an enormous step forward. Being ahead in pharmaceutical technologies, it has ambitions to become one of the most important producers of health nutrition supplements in the Czech Republic, as well as in the whole of Europe. “For 27 years already, we have been following the pathway of innovation, cutting-edge capital investments, and the implementation of revolutionary technologies,” says Martina Pavlová, Managing Director of the company.

n SECRET OF SUCCESS

Two factories, 100 employees and more than 400 products per year. The production programme of FAVEA includes a wide range of solid or semi-solid dosage forms. The company offers innovative dosage forms, such as double-layer tablets, micro-tablets, pellets, pastilles, functional chewing gums, liquid-filled hard capsules, and probiotics. It is a holder of the GMP certificate, which authorises the company to produce human and veterinary medicinal preparations. The upswing of FAVEA is an example of entrepreneurial and technological sucporary market of dietary supplements is beginning to diversify and current trends indicate that high quality standards are essential,” explains Pavlová.

cess. In 2003, it launched pelletisation and granulation technologies. In 2007, the company launched the dosage form of double-layer tablets and, two years later, it presented micronisation. Progress has not stopped either during the last four years, when the company launched, step by step, the production of COMBICAPS® – hard capsules filled with a combination of active substances in solid and oily forms. In the background, there is a large team of leading experts and developers, working on numerous projects in collaboration with prestigious universities. “To keep us top among competitors, we must manufacture high-quality products, respond to market innovations, and look ahead collectively. The contemn EMPHASIS ON EXPORT

The company has also started to export pharmaceutical dietary supplements successfully, with customers being partners worldwide. FAVEA successfully exports to markets of the EU, USA, Australia, and Asia. Contractual partners of the company are high-profile pharmaceutical companies, manufacturers of skincare products and food companies. They also receive product adjustment, pharmaceutical formulation development, innovation of the existing product portfolio, and transfers from FAVEA. “Our long-term wish is that mutual collaboration is always advantageous for both parties. We offer our partners personal approach, flexibility, professionalism, and experience,” adds Pavlová.

n AND THE FUTURE?

“In the near future, we will concentrate increasingly intensively on personalised medicine, meeting the requirements and demands of individual patients and end customers. Among others, we will place emphasis on the breakthrough of COMBICAPS®– greater awareness of the advantages of this form and ultimately a greater utilisation of the production line’s capacity,” concludes Pavlová.

VISION

To become a top producer of dietary supplements worldwide.